Mouse potency assay for Bordetella bronchiseptica bacterins

R. A. Goodnow, C. D. Lehr, F. J. Shade, J. L. Wisecarver

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

A potency assay for Bordetella bronchiseptica bacterins has been developed using mice. The immunogenicities of three bacterins, B, C, and D, were evaluated for ability to prevent death in mice as compared with a reference standard bacterin (RSB-A). Bacterins RSB-A, B and C were evaluated for ability to prevent death in mice as compared with a reference standard bacterin (RSB-A). Bacterins RSB-A and C were evaluated in swine for efficacy against nasal turbinate atrophy. Swine immunized with RSB-A demonstrated 25% gross nasal turbinate atrophy (GNTA), whereas nonimmunized swine had 85% GNTA. Swine vaccinated with bacterins B and C demonstrated 0 and 100% GNTA, respectively, whereas the nonimmunized groups had 64 and 75% GNTA, respectively. RSB-A and bacterins B, C and D provided average mouse survivals of 94, 88, 49, and 32%, respectively when the mice were given 1/10,000 of a recommended swine-immunizing dose, whereas an average of 88% of the unvaccinated mice died.

Original languageEnglish (US)
Pages (from-to)337-339
Number of pages3
JournalJournal of clinical microbiology
Volume6
Issue number4
StatePublished - Dec 1 1977

Fingerprint

Bordetella bronchiseptica
Bacterial Vaccines
Turbinates
Nose
Atrophy
Swine

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Mouse potency assay for Bordetella bronchiseptica bacterins. / Goodnow, R. A.; Lehr, C. D.; Shade, F. J.; Wisecarver, J. L.

In: Journal of clinical microbiology, Vol. 6, No. 4, 01.12.1977, p. 337-339.

Research output: Contribution to journalArticle

Goodnow, RA, Lehr, CD, Shade, FJ & Wisecarver, JL 1977, 'Mouse potency assay for Bordetella bronchiseptica bacterins', Journal of clinical microbiology, vol. 6, no. 4, pp. 337-339.
Goodnow, R. A. ; Lehr, C. D. ; Shade, F. J. ; Wisecarver, J. L. / Mouse potency assay for Bordetella bronchiseptica bacterins. In: Journal of clinical microbiology. 1977 ; Vol. 6, No. 4. pp. 337-339.
@article{d22a7a0a1aa644e09f7a4d9326d7e65e,
title = "Mouse potency assay for Bordetella bronchiseptica bacterins",
abstract = "A potency assay for Bordetella bronchiseptica bacterins has been developed using mice. The immunogenicities of three bacterins, B, C, and D, were evaluated for ability to prevent death in mice as compared with a reference standard bacterin (RSB-A). Bacterins RSB-A, B and C were evaluated for ability to prevent death in mice as compared with a reference standard bacterin (RSB-A). Bacterins RSB-A and C were evaluated in swine for efficacy against nasal turbinate atrophy. Swine immunized with RSB-A demonstrated 25{\%} gross nasal turbinate atrophy (GNTA), whereas nonimmunized swine had 85{\%} GNTA. Swine vaccinated with bacterins B and C demonstrated 0 and 100{\%} GNTA, respectively, whereas the nonimmunized groups had 64 and 75{\%} GNTA, respectively. RSB-A and bacterins B, C and D provided average mouse survivals of 94, 88, 49, and 32{\%}, respectively when the mice were given 1/10,000 of a recommended swine-immunizing dose, whereas an average of 88{\%} of the unvaccinated mice died.",
author = "Goodnow, {R. A.} and Lehr, {C. D.} and Shade, {F. J.} and Wisecarver, {J. L.}",
year = "1977",
month = "12",
day = "1",
language = "English (US)",
volume = "6",
pages = "337--339",
journal = "Journal of Clinical Microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "4",

}

TY - JOUR

T1 - Mouse potency assay for Bordetella bronchiseptica bacterins

AU - Goodnow, R. A.

AU - Lehr, C. D.

AU - Shade, F. J.

AU - Wisecarver, J. L.

PY - 1977/12/1

Y1 - 1977/12/1

N2 - A potency assay for Bordetella bronchiseptica bacterins has been developed using mice. The immunogenicities of three bacterins, B, C, and D, were evaluated for ability to prevent death in mice as compared with a reference standard bacterin (RSB-A). Bacterins RSB-A, B and C were evaluated for ability to prevent death in mice as compared with a reference standard bacterin (RSB-A). Bacterins RSB-A and C were evaluated in swine for efficacy against nasal turbinate atrophy. Swine immunized with RSB-A demonstrated 25% gross nasal turbinate atrophy (GNTA), whereas nonimmunized swine had 85% GNTA. Swine vaccinated with bacterins B and C demonstrated 0 and 100% GNTA, respectively, whereas the nonimmunized groups had 64 and 75% GNTA, respectively. RSB-A and bacterins B, C and D provided average mouse survivals of 94, 88, 49, and 32%, respectively when the mice were given 1/10,000 of a recommended swine-immunizing dose, whereas an average of 88% of the unvaccinated mice died.

AB - A potency assay for Bordetella bronchiseptica bacterins has been developed using mice. The immunogenicities of three bacterins, B, C, and D, were evaluated for ability to prevent death in mice as compared with a reference standard bacterin (RSB-A). Bacterins RSB-A, B and C were evaluated for ability to prevent death in mice as compared with a reference standard bacterin (RSB-A). Bacterins RSB-A and C were evaluated in swine for efficacy against nasal turbinate atrophy. Swine immunized with RSB-A demonstrated 25% gross nasal turbinate atrophy (GNTA), whereas nonimmunized swine had 85% GNTA. Swine vaccinated with bacterins B and C demonstrated 0 and 100% GNTA, respectively, whereas the nonimmunized groups had 64 and 75% GNTA, respectively. RSB-A and bacterins B, C and D provided average mouse survivals of 94, 88, 49, and 32%, respectively when the mice were given 1/10,000 of a recommended swine-immunizing dose, whereas an average of 88% of the unvaccinated mice died.

UR - http://www.scopus.com/inward/record.url?scp=0017660465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017660465&partnerID=8YFLogxK

M3 - Article

C2 - 914991

AN - SCOPUS:0017660465

VL - 6

SP - 337

EP - 339

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 4

ER -